Bay City Capital LLC

This profile gathers the share dealings of Bay City Capital LLC across 3 companies, led by Epizyme, Inc., Madrigal Pharmaceuticals, Inc. and Xilio Therapeutics, Inc. Over a trading history stretching from 12 January 2016 to 3 December 2021, the count stands at 4 filings.

Every open-market trade on record is a purchase: 2 purchases, and no sale. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The latest filing, published on 7 December 2021, reports a transaction in Madrigal Pharmaceuticals, Inc. The last insider purchase was made public on 12 January 2016, 3,932 days ago. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.